Presentation is loading. Please wait.

Presentation is loading. Please wait.

Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer  Tatsuya Yoshimasu, MD, PhD, Shoji Oura, MD, PhD,

Similar presentations


Presentation on theme: "Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer  Tatsuya Yoshimasu, MD, PhD, Shoji Oura, MD, PhD,"— Presentation transcript:

1 Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer 
Tatsuya Yoshimasu, MD, PhD, Shoji Oura, MD, PhD, Fuminori Ohta, MD, Yoshimitsu Hirai, MD, Koma Naito, MD, Rie Nakamura, MD, Haruka Nishiguchi, MD, Sayoko Hashimoto, MD, Mitsumasa Kawago, MD, Yoshitaka Okamura, MD, PhD  Journal of Thoracic Oncology  Volume 6, Issue 10, Pages (October 2011) DOI: /JTO.0b013e318221f71a Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Distribution of inhibition rates for each drug. CDDP, cisplatin; DOC, docetaxel; GEM, gemcitabine; VNR, vinorelbine. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e318221f71a) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer  Tatsuya Yoshimasu, MD, PhD, Shoji Oura, MD, PhD,"

Similar presentations


Ads by Google